We’re improving your experience!

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03179436
Title Safety, Pharmacokinetics (PK), and Efficacy of MK-1308 in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | SWE | POL | NZL | ITA | ISR | GRC | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center ( Site 0013) Gilbert Arizona 85234 United States Details
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0005) Hackensack New Jersey 07601 United States Details
Tennessee Oncology Nashville ( Site 0004) Nashville Tennessee 37203 United States Details
South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001) San Antonio Texas 78229 United States Details
Inova Schar Cancer Institute ( Site 1001) Fairfax Virginia 22031-4867 United States Details
Blacktown Hospital. Western Sydney local health district ( Site 0009) Blacktown New South Wales 2148 Australia Details
Calvary Mater Newcastle ( Site 0025) Waratah New South Wales 2298 Australia Details
Melanoma Institute Australia ( Site 0017) Wollstonecraft New South Wales 2065 Australia Details
Gallipoli Medical Research Foundation-GMRF CTU ( Site 0019) Brisbane Queensland 4120 Australia Details
Cairns and Hinterland Hospital and Health Service ( Site 0020) Cairns Queensland 4870 Australia Details
Ashford Cancer Centre Research ( Site 0012) Kurralta Park South Australia 5037 Australia Details
Ballarat Health Services ( Site 0022) Ballarat Victoria 3350 Australia Details
Alfred Health ( Site 0018) Melbourne Victoria 3004 Australia Details
Sunnybrook Research Institute ( Site 1103) Toronto Ontario M4N 3M5 Canada Details
Princess Margaret Cancer Centre ( Site 1104) Toronto Ontario M5G 2M9 Canada Details
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 1102) Montreal Quebec H2X 0A9 Canada Details
Jewish General Hospital ( Site 1105) Montreal Quebec H3T 1E2 Canada Details
McGill University Health Centre ( Site 1101) Montreal Quebec H4A 3J1 Canada Details
Fundacion Arturo Lopez Perez ( Site 5601) Santiago Region M. De Santiago 7500921 Chile Details
Beijing Cancer hospital-Digestive Oncology ( Site 5001) Beijing Beijing 100142 China Details
Chongqing Cancer Hospital-Phase 1 Unite ( Site 5004) Chongqing Chongqing 400030 China Details
Sir Run Run Shaw Hospital-Medical Oncology ( Site 5003) Hangzhou Zhejiang 310016 China Details
Hopital La Timone ( Site 3303) Marseille Bouches-du-Rhone 13005 France Details
Institut Bergonie ( Site 3306) Bordeaux Gironde 33076 France Details
CHRU Lille - Hopital Claude Huriez ( Site 3302) Lille Nord 59037 France Details
CH Lyon Sud Hospices Civils de Lyon ( Site 3307) Pierre Benite Rhone 69495 France Details
Gustave Roussy ( Site 3305) Villejuif Val-de-Marne 94800 France Details
Regional General Hospital of Athens "Laiko" ( Site 3001) Athens Attiki 115 27 Greece Details
Rambam Medical Center ( Site 0003) Haifa 3109601 Israel Details
Hadassah Ein Karem Hebrew University Medical Center ( Site 0021) Jerusalem 9112001 Israel Details
Sheba Medical Center - Cancer Center ( Site 0002) Ramat-Gan 52621 Israel Details
Istituto Nazionale Tumori Fondazione Pascale ( Site 3903) Napoli 80131 Italy Details
IRCCS Istituto Oncologico Veneto ( Site 3905) Padova 35128 Italy Details
Policlinico Le Scotte - A.O. Senese ( Site 3907) Siena 53100 Italy Details
National Cancer Center Hospital East ( Site 0014) Kashiwa Chiba 277-8577 Japan Details
Hyogo Cancer Center ( Site 0015) Akashi Hyogo 673-8558 Japan Details
Asan Medical Center ( Site 0006) Seoul. Seoul 05505 Korea, Republic of Details
Seoul National University Hospital ( Site 0007) Seoul 03080 Korea, Republic of Details
Severance Hospital Yonsei University Health System ( Site 0008) Seoul 03722 Korea, Republic of Details
Samsung Medical Center ( Site 0010) Seoul 06351 Korea, Republic of Details
Canterbury District Health Board ( Site 0023) Christchurch Canterbury 8011 New Zealand Details
Auckland City Hospital ( Site 0016) Auckland 1023 New Zealand Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Oddzial Badan Wczesnych Faz ( Site 4801 Warszawa Mazowieckie 02-781 Poland Details
Szpital Kliniczny im. Heliodora Swiecickiego Uniwers Medyczn ( Site 4803) Poznan Wielkopolskie 60-780 Poland Details
Sandton Oncology Medical Group PTY LTD ( Site 2701) Johannesburg Gauteng 2196 South Africa Details
Cape Town Oncology Trials Pty Ltd ( Site 2704) Kraaifontein Western Cape 7570 South Africa Details
Cancercare Rondebosch Oncology ( Site 2706) Rondebosch Western Cape 7700 South Africa Details
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 3403) Hospitalet de Llobregat Barcelona 08908 Spain Details
Onkologikoa - Instituto Oncologico de San Sebastian ( Site 3405) San Sebastian Gipuzkoa 20014 Spain Details
Hospital General Universitario de Valencia ( Site 3404) Valencia Valenciana, Comunitat 46014 Spain Details
Hospital Clinic i Provincial de Barcelona ( Site 3401) Barcelona 08036 Spain Details
Hospital Universitario Virgen de la Macarena ( Site 3402) Sevilla 41009 Spain Details
Skanes Universitetssjukhus Lund. ( Site 4601) Lund Skane Lan 221 85 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field